Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,741,379
+$247,098 QoQ
Shares Held
26,544
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#1,380
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $19,966,308 across 13 Drug Manufacturers - General names. JNJ ranks #1 (33.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
26,544 | $6,741,379 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
60,684 | $3,496,612 | |
| 3 | MRK |
Merck & Co., Inc.
|
25,027 | $3,215,969 | |
| 4 | ABBV |
AbbVie Inc.
|
9,790 | $2,463,555 | |
| 5 | LLY |
ELI LILLY & Co
|
1,330 | $1,595,242 | |
| 6 | PFE |
Pfizer Inc
|
42,672 | $1,027,541 | |
| 7 | AMGN |
Amgen Inc
|
2,481 | $898,419 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,234 | $282,243 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,741,379 | 26,544 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,494,281 | 26,568 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,284,450 | 30,367 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,787,329 | 31,212 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,403,989 | 35,378 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,093,790 | 36,745 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,825,054 | 26,449 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,100,928 | 25,305 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,282,168 | 22,456 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,449,332 | 21,805 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,152,825 | 20,115 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,102,540 | 19,920 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,229,957 | 19,514 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,927,020 | 18,884 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,289,399 | 18,621 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,353,944 | 20,531 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,504,934 | 19,745 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,436,666 | 19,391 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,264,870 | 19,085 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,050,089 | 18,886 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,013,259 | 18,291 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,990,183 | 18,194 | Shares | Other | 2021-05-18 | |
| 2020-12-31 | $2,507,692 | 15,934 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $2,297,962 | 15,435 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $2,386,068 | 16,967 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,980,063 | 15,100 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||